Michael B. Mason

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Indianapolis, IN
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ashley Chaffin, as Attorney-in-Fact for Michael B. Mason
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael B. Mason

Form 4 holding EVP & Pres., Lilly Diabetes

ELI LILLY & Co

Security class
Common Stock
Shares / value
39,284
Estimated value
$24,928,448
Report date
10 Feb 2023
Price
$634.57
Ownership
Direct
Form 4 holding EVP & Pres., Lilly Diabetes

ELI LILLY & Co

Security class
Restricted Stock Unit
Shares / value
3,490
Estimated value
$2,062,730
Report date
10 Feb 2023
Price
$591.04
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP & Pres., Lilly Diabetes

ELI LILLY & Co

Security class
Common Stock
Shares / value
957
Estimated value
$607,283
Report date
10 Feb 2023
Price
$634.57
Ownership
401(k)

Insider Reports Filed by Michael B. Mason

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .